These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 10759431

  • 1. Endocrine-disrupting chemicals: prepubertal exposures and effects on sexual maturation and thyroid function in the male rat. A focus on the EDSTAC recommendations. Endocrine Disrupter Screening and Testing Advisory Committee.
    Stoker TE, Parks LG, Gray LE, Cooper RL.
    Crit Rev Toxicol; 2000 Mar; 30(2):197-252. PubMed ID: 10759431
    [Abstract] [Full Text] [Related]

  • 2. Endocrine-disrupting chemicals: prepubertal exposures and effects on sexual maturation and thyroid activity in the female rat. A focus on the EDSTAC recommendations.
    Goldman JM, Laws SC, Balchak SK, Cooper RL, Kavlock RJ.
    Crit Rev Toxicol; 2000 Mar; 30(2):135-96. PubMed ID: 10759430
    [Abstract] [Full Text] [Related]

  • 3. The effect of atrazine on puberty in male wistar rats: an evaluation in the protocol for the assessment of pubertal development and thyroid function.
    Stoker TE, Laws SC, Guidici DL, Cooper RL.
    Toxicol Sci; 2000 Nov; 58(1):50-9. PubMed ID: 11053540
    [Abstract] [Full Text] [Related]

  • 4. Comparison of toxicity studies based on the draft protocol for the 'Enhanced OECD Test Guideline no. 407' and the research protocol of 'Pubertal Development and Thyroid Function in Immature Male Rats' with 6-n-propyl-2-thiouracil.
    Yamasaki K, Tago Y, Nagai K, Sawaki M, Noda S, Takatsuki M.
    Arch Toxicol; 2002 Sep; 76(9):495-501. PubMed ID: 12242606
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of the 20-day pubertal female assay in Sprague-Dawley rats treated with DES, tamoxifen, testosterone, and flutamide.
    Kim HS, Shin JH, Moon HJ, Kim TS, Kang IH, Seok JH, Kim IY, Park KL, Han SY.
    Toxicol Sci; 2002 May; 67(1):52-62. PubMed ID: 11961216
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of ammonium perchlorate in the endocrine disruptor screening and testing program's male pubertal protocol: ability to detect effects on thyroid endpoints.
    Stoker TE, Ferrell JM, Laws SC, Cooper RL, Buckalew A.
    Toxicology; 2006 Nov 10; 228(1):58-65. PubMed ID: 17011691
    [Abstract] [Full Text] [Related]

  • 7. Use of the laboratory rat as a model in endocrine disruptor screening and testing.
    Gray LE, Wilson V, Noriega N, Lambright C, Furr J, Stoker TE, Laws SC, Goldman J, Cooper RL, Foster PM.
    ILAR J; 2004 Nov 10; 45(4):425-37. PubMed ID: 15454681
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of the male pubertal onset assay to detect testosterone and steroid biosynthesis inhibitors in CD rats.
    Marty MS, Crissman JW, Carney EW.
    Toxicol Sci; 2001 Apr 10; 60(2):285-95. PubMed ID: 11248141
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of Tier I screening approaches for detecting endocrine-active compounds (EACs).
    O'Connor JC, Cook JC, Marty MS, Davis LG, Kaplan AM, Carney EW.
    Crit Rev Toxicol; 2002 Apr 10; 32(6):521-49. PubMed ID: 12487364
    [Abstract] [Full Text] [Related]

  • 10. Uncertainties for endocrine disrupters: our view on progress.
    Daston GP, Cook JC, Kavlock RJ.
    Toxicol Sci; 2003 Aug 10; 74(2):245-52. PubMed ID: 12730617
    [Abstract] [Full Text] [Related]

  • 11. Scientific and Regulatory Policy Committee (SRPC) Points to Consider: Histopathology Evaluation of the Pubertal Development and Thyroid Function Assay (OPPTS 890.1450, OPPTS 890.1500) in Rats to Screen for Endocrine Disruptors.
    Keane KA, Parker GA, Regan KS, Picut C, Dixon D, Creasy D, Giri D, Hukkanen RR.
    Toxicol Pathol; 2015 Dec 10; 43(8):1047-63. PubMed ID: 25948506
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of the EDSTAC female pubertal assay in CD rats using 17beta-estradiol, steroid biosynthesis inhibitors, and a thyroid inhibitor.
    Marty MS, Crissman JW, Carney EW.
    Toxicol Sci; 1999 Dec 10; 52(2):269-77. PubMed ID: 10630580
    [Abstract] [Full Text] [Related]

  • 13. Assessment of DE-71, a commercial polybrominated diphenyl ether (PBDE) mixture, in the EDSP male and female pubertal protocols.
    Stoker TE, Laws SC, Crofton KM, Hedge JM, Ferrell JM, Cooper RL.
    Toxicol Sci; 2004 Mar 10; 78(1):144-55. PubMed ID: 14999130
    [Abstract] [Full Text] [Related]

  • 14. Xenoendocrine disrupters-tiered screening and testing: filling key data gaps.
    Gray LE, Ostby J, Wilson V, Lambright C, Bobseine K, Hartig P, Hotchkiss A, Wolf C, Furr J, Price M, Parks L, Cooper RL, Stoker TE, Laws SC, Degitz SJ, Jensen KM, Kahl MD, Korte JJ, Makynen EA, Tietge JE, Ankley GT.
    Toxicology; 2002 Dec 27; 181-182():371-82. PubMed ID: 12505339
    [Abstract] [Full Text] [Related]

  • 15. Screening chemicals for thyroid-disrupting activity: A critical comparison of mammalian and amphibian models.
    Pickford DB.
    Crit Rev Toxicol; 2010 Nov 27; 40(10):845-92. PubMed ID: 20684730
    [Abstract] [Full Text] [Related]

  • 16. Key lessons from performance of the U.S. EPA Endocrine Disruptor Screening Program (EDSP) Tier 1 male and female pubertal assays.
    Stump DG, O'Connor JC, Lewis JM, Marty MS.
    Birth Defects Res B Dev Reprod Toxicol; 2014 Feb 27; 101(1):43-62. PubMed ID: 24510766
    [Abstract] [Full Text] [Related]

  • 17. The effects of simazine, a chlorotriazine herbicide, on pubertal development in the female Wistar rat.
    Zorrilla LM, Gibson EK, Stoker TE.
    Reprod Toxicol; 2010 Jul 27; 29(4):393-400. PubMed ID: 20381603
    [Abstract] [Full Text] [Related]

  • 18. Male pubertal development: are endocrine-disrupting compounds shifting the norms?
    Zawatski W, Lee MM.
    J Endocrinol; 2013 Jul 27; 218(2):R1-12. PubMed ID: 23709001
    [Abstract] [Full Text] [Related]

  • 19. Pubertal exposure to bismerthlazol inhibits thyroid function in juvenile female rats.
    Zhang L, Wang J, Zhu GN.
    Exp Toxicol Pathol; 2009 Sep 27; 61(5):453-9. PubMed ID: 19070471
    [Abstract] [Full Text] [Related]

  • 20. In vitro models in endocrine disruptor screening.
    Charles GD.
    ILAR J; 2004 Sep 27; 45(4):494-501. PubMed ID: 15454688
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.